ad image

Tackling Inflammation with Novel Peptide Drugs

Amytrx Therapeutics

Amytrx Therapeutics

Apr 19, 2022PAO-04-22-R250-67

Along the Road to 50 States, Matthew Gonda, President, CEO, and Founder at Amytrx Therapeutics, Inc., talks to Nigel Walker about Amytrx’s current work with peptides and anti-inflammatory therapies.

ad image
ad image